Search over 3,000 reports

    Actinic Keratosis-Market Insights, Epidemiology and Market Forecast-2023

    Actinic Keratosis-Market Insights, Epidemiology and Market Forecast-2023
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 69
    Geography: Global
    Delivery Timeline: 24 Hours
    SKU: DIMI0003
    DelveInsight's "Actinic Keratosis - Market Insights, Epidemiology and Market Forecast-2023-7MM" report provides an overview of the disease and global market size of the Actinic Keratosis for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Actinic Keratosis from 2013-2023.
    Actinic Keratosis (AK) commonly known as a solar keratosis is a precancerous crusty lesion caused by damage from exposure to ultraviolet (UV) radiation. It is considered a pre-cancer condition if left untreated could develop into a skin cancer, most often squamous cell carcinoma (SCC). AKs appear on areas which are most commonly exposed to sun such as the face, scalp, shoulders, neck, the back of the hands and forearms, etc.
    According to DelveInsight, the market size for Actinic Keratosis in 7 MM is estimated to be USD XX Million by 2023 at a CAGR of 2.5% for the forecast period i.e., 2013-2023. Market size covered in our report, is based only upon the topical therapies approved for Actinic Keratosis.
    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
    Scope
    • The report will help in developing business strategies by understanding the trends shaping and driving the Actinic Keratosis market.
    • Organize sales and marketing efforts by identifying the best opportunities for Actinic Keratosis in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.
    • To understand the future market competition of Actinic Keratosis therapies in the 7MM and Insightful review of the key market drivers and barriers.
    • The report provides historical as well as forecasted epidemiology of Actinic Keratosis in the 7MM.
    • To understand the regulatory scenario in major markets.
    • The Report also covers the detailed historical and forecasted Actinic Keratosis market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.
    Report Introduction 2
    Actinic Keratosis Market Overview at a Glance 9
    7 MM Market Size of Actinic Keratosis (2013-2023) 9
    Total Market Share Distribution of Actinic Keratosis for 7 MM in 2016 10
    Total Market Share Distribution of Actinic Keratosis for 7 MM in 2023 10
    Overview 11
    Signs and symptoms 11
    Risk Factors 11
    Pathophysiology 13
    Diagnosis 15
    Histopathology 15
    Epidemiology and Patient Population 16
    United States 16
    Europe 18
    Germany 19
    France 20
    United Kingdom 21
    Italy 22
    Spain 24
    Japan 26
    Treatment Algorithm 28
    Lesion-Directed Therapies: 29
    Field-Directed Therapies 29
    Photodynamic therapy 30
    Marketed Drugs 32
    Aldara: Valeant Pharmaceuticals 32
    Drug Description 32
    Mechanism of Action 32
    Regulatory Milestones 32
    Advantages & Disadvantages 33
    Safety and Efficacy of Aldara 33
    Product Profile 33
    Zyclara: Valeant Pharmaceuticals 34
    Drug Description 34
    Mechanism of Action 34
    Regulatory Milestones 34
    Advantages & Disadvantages 35
    Safety and Efficacy of Zyclara 35
    Product Profile 36
    Solaraze: Sandoz Pharmaceuticals 37
    Drug Description 37
    Regulatory Milestones 37
    Advantages & Disadvantages 38
    Safety and Efficacy of Solaraze 38
    Product Profile 38
    Efudex: Valeant Pharmaceutical 39
    Drug Description 39
    Mechanism of Action 39
    Regulatory Milestones 39
    Advantages & Disadvantages 39
    Safety and Efficacy of Efudex 40
    Product Profile 40
    Carac: Valeant Pharmaceuticals 41
    Drug Description 41
    Mechanism of Action 41
    Regulatory Milestones 41
    Advantages & Disadvantages 41
    Safety and Efficacy of Carac 42
    Product Profile 42
    Emerging Therapies 43
    LEO 43204: Leo Pharma 43
    Clinical Pipeline Activity 44
    Ongoing Trials Information 45
    Safety and Efficacy 47
    Advantages & Disadvantages 48
    Product Profile 48
    GDC695: Gage Development Company 49
    Clinical Trials Information 49
    Product Profile 49
    Actinic Keratosis: Region-Specific Market Analysis 50
    Region-Specific Market Distribution and Comparison 50
    Overview on Actinic Keratosis Market (2016) 50
    Overview on Total Actinic Keratosis Market (2023) 51
    Global Market Outlook -Actinic Keratosis 52
    United States 53
    Market Outlook 53
    Market Size 54
    Europe 55
    Market Outlook 55
    Germany 56
    Market Size 56
    France 57
    Market Size 57
    United Kingdom 58
    Market Size 58
    Spain 59
    Market Size 59
    Italy 60
    Market Size 60
    Japan 61
    Market Outlook 61
    Market Size 62
    Market Drivers 63
    Market Barriers 64
    Unmet Needs 65
    Report Methodology 66
    Consulting Services 68
    Disclaimer 69
    About DelveInsight 69
    Table 1: 7 MM Market Size of Actinic Keratosis in USD Million (2013-2023) 8
    Table 2: Prevalent and Treatable Population of Actinic Keratosis in United States (2013-2023) 16
    Table 3: Prevalent and Treatable Population of Actinic Keratosis in Germany (2013-2023) 18
    Table 4: Prevalent and Treatable Population of Actinic Keratosis in France (2013-2023) 19
    Table 5: Prevalent and Treatable Population of Actinic Keratosis in United Kingdom (2013-2023) 21
    Table 6: Prevalent and Treatable Population of Actinic Keratosis in Italy (2013-2023) 22
    Table 7: Prevalent and Treatable Population of Actinic Keratosis in Spain (2013-2023) 24
    Table 8: Prevalent and Treatable Population of Actinic Keratosis in Japan(2013-2023) 26
    Table 9: LEO 43204, Clinical Trials by Zone, 2017 43
    Table 10: United States Market Size of Actinic Keratosis in USD, Million (2013-2023) 53
    Table 11: Germany Market Size of Actinic Keratosis in USD, Million (2013-2023) 55
    Table 12: France Market Size of Actinic Keratosis in USD, Million (2013-2023) 56
    Table 13: United Kingdom Market Size of Actinic Keratosis in USD, Million (2013-2023) 57
    Table 14: Spain Market Size of Actinic Keratosis in USD, Million (2013-2023) 58
    Table 15: Italy Market Size of Actinic Keratosis in USD, Million (2013-2023) 59
    Table 16: Japan Market Size of Actinic Keratosis in USD, Million (2013-2023) 61
    Figure 1: Risk Factors of Actinic Keratosis 11
    Figure 2: Pathophysiology of Actinic Keratosis 13
    Figure 3: Prevalent and Treatable Population of Actinic Keratosis in United States (2013-2023) 16
    Figure 4: Prevalent and Treatable Population of Actinic Keratosis in Germany(2013-2023) 18
    Figure 5: Prevalent and Treatable Population of Actinic Keratosis in France(2013-2023) 19
    Figure 6: Prevalent and Treatable Population of Actinic Keratosis in United Kingdom (2013-2023) 20
    Figure 7: Prevalent and Treatable Population of Actinic Keratosis in Italy (2013-2023) 22
    Figure 8: Prevalent and Treatable Population of Actinic Keratosis in Spain (2013-2023) 24
    Figure 9: Prevalent and Treatable Population of Actinic Keratosis in Japan (2013-2023) 26
    Figure 10:Treatment Algorithm for Actinic Keratosis 27
    Figure 11: LEO 43204, Clinical Trials by Zone (%), 2017 43
    Figure 12: LEO 43204, Clinical Trials by Recruitment status (%), 2017 44
    Figure 13: Region specific market distribution and comparison 49
    Figure 14: Total7 Major Market Size of Actinic Keratosis in USD, Million (2016) 49
    Figure 15: Total7 Major Market Size of Actinic Keratosis in USD, Million (2023) 50
    Figure 16: United States Market Size of Actinic Keratosis in USD, Million (2013-2023) 53
    Figure 17: Germany Market Size of Actinic Keratosis in USD, Million (2013-2023) 55
    Figure 18: France Market Size of Actinic Keratosis in USD, Million (2013-2023) 56
    Figure 19: United Kingdom Market Size of Actinic Keratosis in USD, Million (2013-2023) 57
    Figure 20: Spain Market Size of Actinic Keratosis in USD, Million (2013-2023) 58
    Figure 21: Italy Market Size of Actinic Keratosis in USD, Million (2013-2023) 59
    Figure 22: Japan Market Size of Actinic Keratosis in USD, Million (2013-2023) 61
    Actinic Keratosis Market (7MM)

    Actinic Keratosis Market forecasting

    Actinic Keratosis Sales forecasting

    Actinic Keratosis Market segments

    Actinic Keratosis Epidemiology

    Actinic Keratosis Pipeline products and technologies

    Actinic Keratosis Competitive landscape

    Actinic Keratosis SWOT analysis

    Actinic Keratosis Market Driver's and barriers

    Actinic Keratosis Key Companies and Funding

    • Single User License
      (20% Off)
      $4,950.00
      $3960
    • Site License
      (30% Off)
      $9,900.00
      $6930
    • Global License
      (40% Off)
      $14,850.00
      $8910

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap